CME Group Inc. (NASDAQ:CME) Position Reduced by Chevy Chase Trust Holdings LLC

Chevy Chase Trust Holdings LLC reduced its position in CME Group Inc. (NASDAQ:CME) by 1.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 197,547 shares of the financial services provider’s stock after selling 3,664 shares during the period. Chevy Chase Trust Holdings LLC owned about 0.05% of CME Group worth $43,589,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Truvestments Capital LLC acquired a new stake in CME Group during the 3rd quarter valued at $26,000. Y.D. More Investments Ltd purchased a new stake in CME Group in the 2nd quarter worth about $36,000. McClarren Financial Advisors Inc. lifted its stake in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after acquiring an additional 78 shares in the last quarter. Asset Dedication LLC boosted its position in CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 170 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. grew its stake in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In related news, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the transaction, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 15.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Martin J. Gepsman sold 400 shares of the stock in a transaction on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the sale, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,028 shares of company stock valued at $1,811,681. Insiders own 0.30% of the company’s stock.

CME Group Stock Down 1.0 %

CME opened at $235.61 on Tuesday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $238.97. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The business has a 50 day moving average price of $225.55 and a 200 day moving average price of $211.96. The firm has a market cap of $84.90 billion, a P/E ratio of 24.77, a price-to-earnings-growth ratio of 5.49 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. CME Group’s revenue was up 18.4% compared to the same quarter last year. During the same period last year, the business posted $2.25 EPS. Research analysts forecast that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 1.95%. CME Group’s payout ratio is presently 48.37%.

Analysts Set New Price Targets

Several analysts recently commented on CME shares. Barclays raised their price target on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Piper Sandler upped their price target on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Bank of America lifted their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Finally, Citigroup boosted their target price on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $224.47.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.